SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Health/Beauty

PUBLISHER: Grand View Research | PRODUCT CODE: 2132496

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132496

Condom Market Size, Share & Trends Analysis Report By Material Type (Latex, Non-latex), By Product (Male Condom, Female Condom), By Distribution Channel (Public Health Distribution, E-commerce), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Condom Market Summary

The global condom market size was valued at USD 13.6 billion in 2025 and is projected to grow from USD 14.8 billion in 2026 to USD 27.0 billion by 2033, at a CAGR of 9.0% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 51.9% in 2025.

Global Condom Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global condom market report based on material type, product, distribution channel, MEA condom market by distribution channel, and region:

  • Material Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Latex Condoms
  • Non-latex Condoms
    • Polyurethane and Polyisoprene
    • Lambskin
    • Nitrile Butadiene Rubber (NBR)
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Male Condoms
  • Female Condoms
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Public Health Distribution
  • Drug Stores
  • E-commerce
  • Mass Merchandizers
  • MEA Condom Market by Distribution Channel (Revenue, USD Million, 2021 - 2033)
  • Public Sector
  • Social Marketing
  • Commercial Sector
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
    • Netherlands
    • Switzerland
    • Portugal
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Nigeria
    • Kenya
    • Zambia
    • Zimbabwe
    • Uganda
    • Egypt
    • Turkey
    • Ghana
Show more
Product Code: GVR-3-68038-272-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources & Third-Party Perspectives
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Material Type Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. MEA Condom Market Distribution Channel Outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing prevalence of HIV infections and STD
      • 3.3.1.2. Favorable government initiatives
      • 3.3.1.3. Increasing penetration of online retailers
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Social and cultural stigma in developing countries
      • 3.3.2.2. Market entry barriers in African countries
    • 3.3.3. Industry Opportunities
      • 3.3.3.1. Technological advancements
    • 3.3.4. Industry Challenges
      • 3.3.4.1. Adverse effects from materials used in condoms
  • 3.4. Business Environment Analysis
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
  • 3.5. Average Regional Pricing Analysis of Different Variants of Condoms
  • 3.6. Qualitative Analysis: Supply Chain Analysis of Condoms, by Material Type
  • 3.7. Estimated Profit Margin Analysis for Condom Manufacturing Companies, 2025

Chapter 4. Material Type Business Analysis

  • 4.1. Condom Market: Material Type Movement Analysis
  • 4.2. Condom Material Type Market: Segment Dashboard
  • 4.3. Material Type Movement & Market Share Analysis, 2023 & 2033
  • 4.4. Global Condom Market Estimates & Forecast, by Material Type
  • 4.5. Latex
    • 4.5.1. Latex market, 2021 - 2033 (USD Million)
  • 4.6. Non-Latex
    • 4.6.1. Non-Latex market, 2021 - 2033 (USD Million)
    • 4.6.2. Polyurethane Polyisoprene
      • 4.6.2.1. Polyurethane polyisoprene market, 2021 - 2033 (USD Million)
    • 4.6.3. Polyisoprene
      • 4.6.3.1. Polyisoprene market, 2021 - 2033 (USD Million)
    • 4.6.4. Lambskin
      • 4.6.4.1. Lambskin market, 2021 - 2033 (USD Million)
    • 4.6.5. Nitrile Butadiene Rubber (NBR)
      • 4.6.5.1. Nitrile Butadiene Rubber (NBR) market, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Condom Market: Product Movement Analysis
  • 5.2. Condom Product Market: Segment Dashboard
  • 5.3. Product Movement & Market Share Analysis, 2023 & 2033
  • 5.4. Global Condom Market Estimates & Forecast, by Product
  • 5.5. Male Condom
    • 5.5.1. Male condom market, 2021 - 2033 (USD Million)
  • 5.6. Female Condom
    • 5.6.1. Female condom market, 2021 - 2033 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Condom Market: Distribution Channel Movement Analysis
  • 6.2. Condom Distribution Channel Market: Segment Dashboard
  • 6.3. Distribution Channel Movement & Market Share Analysis, 2023 & 2033
  • 6.4. Global Condom Market Estimates & Forecast, by Distribution Channel
  • 6.5. Public Health Distribution
    • 6.5.1. Public health distribution market, 2021 - 2033 (USD Million)
  • 6.6. Drug Stores
    • 6.6.1. Drug stores market, 2021 - 2033 (USD Million)
  • 6.7. E-commerce
    • 6.7.1. E-commerce market, 2021 - 2033 (USD Million)
  • 6.8. Mass Merchandizers
    • 6.8.1. Mass Merchandizers market, 2021 - 2033 (USD Million)

Chapter 7. MEA Condom Market Distribution Channel Business Analysis

  • 7.1. MEA Condom Market: Distribution Channel Movement Analysis
  • 7.2. MEA Condom Distribution Channel Market: Segment Dashboard
  • 7.3. Distribution Channel Movement & Market Share Analysis, 2023 & 2033
  • 7.4. MEA Condom Market Estimates & Forecast, by Distribution Channel
  • 7.5. Public Sector
    • 7.5.1. Public sector market, 2021 - 2033 (USD Million)
  • 7.6. Social Marketing
    • 7.6.1. Social marketing market, 2021 - 2033 (USD Million)
  • 7.7. Commercial Sector
    • 7.7.1. Commercial sector market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.5. North America
    • 8.5.1. North America Condom Market, 2021 - 2033 (USD Billion)
    • 8.5.2. U.S.
      • 8.5.2.1. U.S. estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.5.2.2. Regulatory framework/scenario
      • 8.5.2.3. Reimbursement scenario
      • 8.5.2.4. Competitive scenario
      • 8.5.2.5. U.S. Condom, 2021 - 2033 (USD million)
      • 8.5.2.6. U.S. condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.5.3. Canada
      • 8.5.3.1. Canada estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.5.3.2. Regulatory framework/scenario
      • 8.5.3.3. Reimbursement scenario
      • 8.5.3.4. Competitive scenario
      • 8.5.3.5. Canada Condom, 2021 - 2033 (USD million)
      • 8.5.3.6. Canada condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.5.4. Mexico
      • 8.5.4.1. Mexico estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.5.4.2. Regulatory framework/scenario
      • 8.5.4.3. Reimbursement scenario
      • 8.5.4.4. Competitive scenario
      • 8.5.4.5. Mexico condom market, 2021 - 2033 (USD million)
      • 8.5.4.6. Mexico condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • 8.6. Europe
    • 8.6.1. Europe Condom Market, 2021 - 2033 (USD Million)
    • 8.6.2. UK
      • 8.6.2.1. UK estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.2.2. Regulatory framework/scenario
      • 8.6.2.3. Reimbursement scenario
      • 8.6.2.4. Competitive scenario
      • 8.6.2.5. UK condom market, 2021 - 2033 (USD million)
      • 8.6.2.6. UK condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.3. Germany
      • 8.6.3.1. Germany estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.3.2. Regulatory framework/scenario
      • 8.6.3.3. Reimbursement scenario
      • 8.6.3.4. Competitive scenario
      • 8.6.3.5. Germany condom market, 2021 - 2033 (USD million)
      • 8.6.3.6. Germany condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.4. France
      • 8.6.4.1. France estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.4.2. Regulatory framework/scenario
      • 8.6.4.3. Reimbursement scenario
      • 8.6.4.4. Competitive scenario
      • 8.6.4.5. France condom market, 2021 - 2033 (USD million)
      • 8.6.4.6. France condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.5. Italy
      • 8.6.5.1. Italy estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.5.2. Regulatory framework/scenario
      • 8.6.5.3. Reimbursement scenario
      • 8.6.5.4. Competitive scenario
      • 8.6.5.5. Italy condom market, 2021 - 2033 (USD million)
      • 8.6.5.6. Italy condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.6. Spain
      • 8.6.6.1. Spain estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.6.2. Regulatory framework/scenario
      • 8.6.6.3. Reimbursement scenario
      • 8.6.6.4. Competitive scenario
      • 8.6.6.5. Spain condom market, 2021 - 2033 (USD million)
      • 8.6.6.6. Spain condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.7. Sweden
      • 8.6.7.1. Sweden estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.7.2. Regulatory framework/scenario
      • 8.6.7.3. Reimbursement scenario
      • 8.6.7.4. Competitive scenario
      • 8.6.7.5. Sweden condom market, 2021 - 2033 (USD million)
      • 8.6.7.6. Sweden condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.8. Norway
      • 8.6.8.1. Norway estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.8.2. Regulatory framework/scenario
      • 8.6.8.3. Reimbursement scenario
      • 8.6.8.4. Competitive scenario
      • 8.6.8.5. Norway condom market, 2021 - 2033 (USD million)
      • 8.6.8.6. Norway condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.9. Netherlands
      • 8.6.9.1. Netherlands estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.9.2. Regulatory framework/scenario
      • 8.6.9.3. Reimbursement scenario
      • 8.6.9.4. Competitive scenario
      • 8.6.9.5. Netherlands condom market, 2021 - 2033 (USD million)
      • 8.6.9.6. Netherlands condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.10. Switzerland
      • 8.6.10.1. Switzerland estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.10.2. Regulatory framework/scenario
      • 8.6.10.3. Reimbursement scenario
      • 8.6.10.4. Competitive scenario
      • 8.6.10.5. Switzerland condom market, 2021 - 2033 (USD million)
      • 8.6.10.6. Switzerland condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.11. Portugal
      • 8.6.11.1. Portugal estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.11.2. Regulatory framework/scenario
      • 8.6.11.3. Reimbursement scenario
      • 8.6.11.4. Competitive scenario
      • 8.6.11.5. Portugal condom market, 2021 - 2033 (USD million)
      • 8.6.11.6. Portugal condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.6.12. Denmark
      • 8.6.12.1. Denmark estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.6.12.2. Regulatory framework/scenario
      • 8.6.12.3. Reimbursement scenario
      • 8.6.12.4. Competitive scenario
      • 8.6.12.5. Denmark condom market, 2021 - 2033 (USD million)
      • 8.6.12.6. Denmark condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific Condom Market, 2021 - 2033 (USD Billion)
    • 8.7.2. Japan
      • 8.7.2.1. Japan estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.2.2. Regulatory framework/scenario
      • 8.7.2.3. Reimbursement scenario
      • 8.7.2.4. Competitive scenario
      • 8.7.2.5. Japan condom market, 2021 - 2033 (USD million)
      • 8.7.2.6. Japan condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.7.3. China
      • 8.7.3.1. China estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.3.2. Regulatory framework/scenario
      • 8.7.3.3. Reimbursement scenario
      • 8.7.3.4. Competitive scenario
      • 8.7.3.5. China condom market, 2021 - 2033 (USD million)
      • 8.7.3.6. China condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.7.4. India
      • 8.7.4.1. India estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.4.2. Regulatory framework/scenario
      • 8.7.4.3. Reimbursement scenario
      • 8.7.4.4. Competitive scenario
      • 8.7.4.5. India condom market, 2021 - 2033 (USD million)
      • 8.7.4.6. India condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.7.5. Australia
      • 8.7.5.1. Australia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.5.2. Regulatory framework/scenario
      • 8.7.5.3. Reimbursement scenario
      • 8.7.5.4. Competitive scenario
      • 8.7.5.5. Australia condom market, 2021 - 2033 (USD million)
      • 8.7.5.6. Australia condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.7.6. Thailand
      • 8.7.6.1. Thailand estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.6.2. Regulatory framework/scenario
      • 8.7.6.3. Reimbursement scenario
      • 8.7.6.4. Competitive scenario
      • 8.7.6.5. Thailand condom market, 2021 - 2033 (USD million)
      • 8.7.6.6. Thailand condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.7.7. South Korea
      • 8.7.7.1. South Korea estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.7.7.2. Regulatory framework/scenario
      • 8.7.7.3. Reimbursement scenario
      • 8.7.7.4. Competitive scenario
      • 8.7.7.5. South Korea condom market, 2021 - 2033 (USD million)
      • 8.7.7.6. South Korea condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • 8.8. Latin America
    • 8.8.1. Latin America Condom Market, 2021 - 2033 (USD Billion)
    • 8.8.2. Brazil
      • 8.8.2.1. Brazil estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.8.2.2. Regulatory framework/scenario
      • 8.8.2.3. Reimbursement scenario
      • 8.8.2.4. Competitive scenario
      • 8.8.2.5. Brazil condom market, 2021 - 2033 (USD million)
      • 8.8.2.6. Brazil condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.8.3. Argentina
      • 8.8.3.1. Argentina estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.8.3.2. Regulatory framework/scenario
      • 8.8.3.3. Reimbursement scenario
      • 8.8.3.4. Competitive scenario
      • 8.8.3.5. Argentina condom market, 2021 - 2033 (USD million)
      • 8.8.3.6. Argentina condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • 8.9. MEA
    • 8.9.1. MEA Condom Market, 2021 - 2033 (USD Billion)
    • 8.9.2. South Africa
      • 8.9.2.1. South Africa estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.2.2. Regulatory framework/scenario
      • 8.9.2.3. Reimbursement scenario
      • 8.9.2.4. Competitive scenario
      • 8.9.2.5. South Africa condom market, 2021 - 2033 (USD million)
      • 8.9.2.6. South Africa condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Saudi Arabia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.3.2. Regulatory framework/scenario
      • 8.9.3.3. Reimbursement scenario
      • 8.9.3.4. Competitive scenario
      • 8.9.3.5. Saudi Arabia condom market, 2021 - 2033 (USD million)
      • 8.9.3.6. Saudi Arabia condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.4. UAE
      • 8.9.4.1. UAE estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.4.2. Regulatory framework/scenario
      • 8.9.4.3. Reimbursement scenario
      • 8.9.4.4. Competitive scenario
      • 8.9.4.5. UAE condom market, 2021 - 2033 (USD million)
      • 8.9.4.6. UAE condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.5. Kuwait
      • 8.9.5.1. Kuwait estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.5.2. Regulatory framework/scenario
      • 8.9.5.3. Reimbursement scenario
      • 8.9.5.4. Competitive scenario
      • 8.9.5.5. Kuwait condom market, 2021 - 2033 (USD million)
      • 8.9.5.6. Kuwait condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.6. Nigeria
      • 8.9.6.1. Nigeria estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.6.2. Regulatory framework/scenario
      • 8.9.6.3. Reimbursement scenario
      • 8.9.6.4. Competitive scenario
      • 8.9.6.5. Nigeria condom market, 2021 - 2033 (USD million)
      • 8.9.6.6. Nigeria condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.7. Kenya
      • 8.9.7.1. Kenya estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.7.2. Regulatory framework/scenario
      • 8.9.7.3. Reimbursement scenario
      • 8.9.7.4. Competitive scenario
      • 8.9.7.5. Kenya condom market, 2021 - 2033 (USD million)
      • 8.9.7.6. Kenya condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.8. Zambia
      • 8.9.8.1. Zambia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.8.2. Regulatory framework/scenario
      • 8.9.8.3. Reimbursement scenario
      • 8.9.8.4. Competitive scenario
      • 8.9.8.5. Zambia condom market, 2021 - 2033 (USD million)
      • 8.9.8.6. Zambia condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.9. Zimbabwe
      • 8.9.9.1. Zimbabwe estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.9.2. Regulatory framework/scenario
      • 8.9.9.3. Reimbursement scenario
      • 8.9.9.4. Competitive scenario
      • 8.9.9.5. Zimbabwe condom market, 2021 - 2033 (USD million)
      • 8.9.9.6. Zimbabwe condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.10. Uganda
      • 8.9.10.1. Uganda estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.10.2. Regulatory framework/scenario
      • 8.9.10.3. Reimbursement scenario
      • 8.9.10.4. Competitive scenario
      • 8.9.10.5. Uganda condom market, 2021 - 2033 (USD million)
      • 8.9.10.6. Uganda condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.11. Egypt
      • 8.9.11.1. Egypt estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.11.2. Regulatory framework/scenario
      • 8.9.11.3. Reimbursement scenario
      • 8.9.11.4. Competitive scenario
      • 8.9.11.5. Egypt condom market, 2021 - 2033 (USD million)
      • 8.9.11.6. Egypt condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.12. Turkey
      • 8.9.12.1. Turkey estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.12.2. Regulatory framework/scenario
      • 8.9.12.3. Reimbursement scenario
      • 8.9.12.4. Competitive scenario
      • 8.9.12.5. Turkey condom market, 2021 - 2033 (USD million)
      • 8.9.12.6. Turkey condom market volume estimates and forecasts, 2021 - 2033 ('000)
    • 8.9.13. Ghana
      • 8.9.13.1. Ghana estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
      • 8.9.13.2. Regulatory framework/scenario
      • 8.9.13.3. Reimbursement scenario
      • 8.9.13.4. Competitive scenario
      • 8.9.13.5. Ghana condom market, 2021 - 2033 (USD million)
      • 8.9.13.6. Ghana condom market volume estimates and forecasts, 2021 - 2033 ('000)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Position Analysis
  • 9.3. Strategy Mapping
    • 9.3.1. Expansion
    • 9.3.2. Acquisition
    • 9.3.3. Collaborations
    • 9.3.4. Others
  • 9.4. Company Profiles/Listing
    • 9.4.1. FUJILATEX CO.,LTD
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Reckitt
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Church & Dwight Co., Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Karex Berhad
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. LELO iAB
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Lifestyles
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Okamoto Industries, Inc
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
      • 9.4.7.5. Strategic Initiatives
    • 9.4.8. MAYER LABORATORIES, INC.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Cupid Limited
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. RITEX GMBH
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Pasante Healthcare Ltd.
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. CPR GmbH
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Mankind Pharma
      • 9.4.13.1. Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Sagami Rubber Industries Co., Ltd.
      • 9.4.14.1. Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. rrtMedcon
      • 9.4.15.1. Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives
Show more
Product Code: GVR-3-68038-272-3

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global condom market, by material type, 2021 - 2033 (USD Million)
  • Table 4. Global condom market, by product, 2021 - 2033 (USD Million)
  • Table 5. Global condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6. Global condom market, by region, 2021 - 2033 (USD Million)
  • Table 7. North America condom market, by country, 2021 - 2033 (USD Million)
  • Table 8. North America condom market, by material type, 2021 - 2033 (USD Million)
  • Table 9. North America condom market, by product, 2021 - 2033 (USD Million)
  • Table 10. North America condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11. U.S.condom market, by material type, 2021 - 2033 (USD Million)
  • Table 12. U.S.condom market, by product, 2021 - 2033 (USD Million)
  • Table 13. U.S. Condom, by distribution channel, 2021 - 2033 (USD Million)
  • Table 14. Canada Condom, by material type, 2021 - 2033 (USD Million)
  • Table 15. Canada Condom, by product, 2021 - 2033 (USD Million)
  • Table 16. Canada Condom, by distribution channel, 2021 - 2033 (USD Million)
  • Table 17. Mexico condom market, by material type, 2021 - 2033 (USD Million)
  • Table 18. Mexico condom market, by product, 2021 - 2033 (USD Million)
  • Table 19. Mexico condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20. Europe condom market, by country, 2021 - 2033 (USD Million)
  • Table 21. Europe condom market, by material type, 2021 - 2033 (USD Million)
  • Table 22. Europe condom market, by product, 2021 - 2033 (USD Million)
  • Table 23. Europe condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24. UK condom market, by material type, 2021 - 2033 (USD Million)
  • Table 25. UK condom market, by product, 2021 - 2033 (USD Million)
  • Table 26. UK condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 27. Germany condom market, by material type, 2021 - 2033 (USD Million)
  • Table 28. Germany condom market, by product, 2021 - 2033 (USD Million)
  • Table 29. Germany condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30. France condom market, by material type, 2021 - 2033 (USD Million)
  • Table 31. France condom market, by product, 2021 - 2033 (USD Million)
  • Table 32. France condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 33. Italy condom market, by material type, 2021 - 2033 (USD Million)
  • Table 34. Italy condom market, by product, 2021 - 2033 (USD Million)
  • Table 35. Italy condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36. Spain condom market, by material type, 2021 - 2033 (USD Million)
  • Table 37. Spain condom market, by product, 2021 - 2033 (USD Million)
  • Table 38. Spain condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39. Sweden condom market, by material type, 2021 - 2033 (USD Million)
  • Table 40. Sweden condom market, by product, 2021 - 2033 (USD Million)
  • Table 41. Sweden condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42. Norway condom market, by material type, 2021 - 2033 (USD Million)
  • Table 43. Norway condom market, by product, 2021 - 2033 (USD Million)
  • Table 44. Norway condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45. Denmark condom market, by material type, 2021 - 2033 (USD Million)
  • Table 46. Denmark condom market, by product, 2021 - 2033 (USD Million)
  • Table 47. Denmark condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific condom market, by country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific speech condom market, by material type, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific speech condom market, by product, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52. Japan condom market, by material type, 2021 - 2033 (USD Million)
  • Table 53. Japan condom market, by product, 2021 - 2033 (USD Million)
  • Table 54. Japan condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 55. China condom market, by material type, 2021 - 2033 (USD Million)
  • Table 56. China condom market, by product, 2021 - 2033 (USD Million)
  • Table 57. China condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58. India condom market, by material type, 2021 - 2033 (USD Million)
  • Table 59. India condom market, by product, 2021 - 2033 (USD Million)
  • Table 60. India condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61. Australia condom market, by material type, 2021 - 2033 (USD Million)
  • Table 62. Australia condom market, by product, 2021 - 2033 (USD Million)
  • Table 63. Australia condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 64. Thailand condom market, by material type, 2021 - 2033 (USD Million)
  • Table 65. Thailand condom market, by product, 2021 - 2033 (USD Million)
  • Table 66. Thailand condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 67. South Korea condom market, by material type, 2021 - 2033 (USD Million)
  • Table 68. South Korea condom market, by product, 2021 - 2033 (USD Million)
  • Table 69. South Korea condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70. Latin America condom market, by country, 2021 - 2033 (USD Million)
  • Table 71. Latin America condom market, by material type, 2021 - 2033 (USD Million)
  • Table 72. Latin America condom market, by product, 2021 - 2033 (USD Million)
  • Table 73. Latin America condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 74. Brazil condom market, by material type, 2021 - 2033 (USD Million)
  • Table 75. Brazil condom market, by product, 2021 - 2033 (USD Million)
  • Table 76. Brazil condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77. Argentina condom market, by material type, 2021 - 2033 (USD Million)
  • Table 78. Argentina condom market, by product, 2021 - 2033 (USD Million)
  • Table 79. Argentina condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa condom market, by country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa condom market, by material type, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa condom market, by product, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 84. South Africa condom market, by material type, 2021 - 2033 (USD Million)
  • Table 85. South Africa condom market, by product, 2021 - 2033 (USD Million)
  • Table 86. South Africa condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia condom market, by material type, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia condom market, by product, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90. UAE condom market, by material type, 2021 - 2033 (USD Million)
  • Table 91. UAE condom market, by product, 2021 - 2033 (USD Million)
  • Table 92. UAE condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93. Kuwait condom market, by material type, 2021 - 2033 (USD Million)
  • Table 94. Kuwait condom market, by product, 2021 - 2033 (USD Million)
  • Table 95. Kuwait condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 96. Nigeria condom market, by material type, 2021 - 2033 (USD Million)
  • Table 97. Nigeria condom market, by product, 2021 - 2033 (USD Million)
  • Table 98. Nigeria condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 99. Kenya condom market, by material type, 2021 - 2033 (USD Million)
  • Table 100. Kenya condom market, by product, 2021 - 2033 (USD Million)
  • Table 101. Kenya condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 102. Zambia condom market, by material type, 2021 - 2033 (USD Million)
  • Table 103. Zambia condom market, by product, 2021 - 2033 (USD Million)
  • Table 104. Zambia condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 105. Zimbabwe condom market, by material type, 2021 - 2033 (USD Million)
  • Table 106. Zimbabwe condom market, by product, 2021 - 2033 (USD Million)
  • Table 107. Zimbabwe condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 108. Uganda condom market, by material type, 2021 - 2033 (USD Million)
  • Table 109. Uganda condom market, by product, 2021 - 2033 (USD Million)
  • Table 110. Uganda condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 111. Egypt condom market, by material type, 2021 - 2033 (USD Million)
  • Table 112. Egypt condom market, by product, 2021 - 2033 (USD Million)
  • Table 113. Egypt condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 114. Turkey condom market, by material type, 2021 - 2033 (USD Million)
  • Table 115. Turkey condom market, by product, 2021 - 2033 (USD Million)
  • Table 116. Turkey condom market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 117. Ghana condom market, by material type, 2021 - 2033 (USD Million)
  • Table 118. Ghana condom market, by product, 2021 - 2033 (USD Million)
  • Table 119. Ghana condom market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1. Market research process
  • Fig 2. Condom market segmentation
  • Fig 3. Market research process
  • Fig 4. Data triangulation techniques
  • Fig 5. Primary research pattern
  • Fig 6. Market research approaches
  • Fig 7. Value-chain-based sizing & forecasting
  • Fig 8. QFD modelling for market share assessment
  • Fig 9. Market formulation & validation
  • Fig 10. Market snapshot
  • Fig 11. Market segmentation
  • Fig 12. Market segmentation
  • Fig 13. Competitive landscape
  • Fig 14. Global condom market lineage outlook
  • Fig 15. Condom market dynamics
  • Fig 16. Market driver relevance analysis (Current & future impact)
  • Fig 17. Market restraint relevance analysis (Current & future impact)
  • Fig 18. Supply chain analysis: Condom market
  • Fig 19. Condom market: Porter's five forces analysis
  • Fig 20. Condom market: PESTLE analysis
  • Fig 21. Condom market material type outlook: Segment dashboard)
  • Fig 22. Condom market: Material type movement & market share analysis, 2023 & 2033
  • Fig 23. Latex condom market, 2021 - 2033 (USD Million)
  • Fig 24. Non latex condom market, 2021- 2033 (USD Million)
  • Fig 25. Polyurethane market, 2021 - 2033 (USD Million)
  • Fig 26. Polyisoprene market, 2021 - 2033 (USD Million)
  • Fig 27. Lambskin market, 2021 - 2033 (USD Million)
  • Fig 28. Nitrile Butadiene Rubber (NBR) market, 2021 - 2033 (USD Million)
  • Fig 29. Condom market product outlook: Segment dashboard
  • Fig 30. Condom market: Product movement & market share analysis, 2023 & 2033
  • Fig 31. Male condom market, 2021 - 2033 (USD Million)
  • Fig 32. Female condom market, 2021 - 2033 (USD Million)
  • Fig 33. Condom market distribution channel outlook: Segment dashboard)
  • Fig 34. Condom market: Distribution channel movement & market share analysis, 2023 & 2033
  • Fig 35. Public health distribution market, 2021 - 2033 (USD Million)
  • Fig 36. Drug stores market, 2021 - 2033 (USD Million)
  • Fig 37. E-commerce market, 2021 - 2033 (USD Million)
  • Fig 38. Mass merchandizers market, 2021 - 2033 (USD Million)
  • Fig 39. MEA condom market distribution channel outlook: Segment dashboard)
  • Fig 40. MEA condom market: Distribution channel movement & market share analysis, 2023 & 2033
  • Fig 41. Public sector market, 2021 - 2033 (USD Million)
  • Fig 42. Social marketing market, 2021 - 2033 (USD Million)
  • Fig 43. Commercial sector market, 2021 - 2033 (USD Million)
  • Fig 44. Regional marketplace: Key takeaways
  • Fig 45. Regional key marketplace takeaway
  • Fig 46. Regional key marketplace takeaway
  • Fig 47. Regional key marketplace takeaway
  • Fig 48. North America condom market, 2021 - 2033 (USD Million)
  • Fig 49. North America condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 50. U.S. estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 51. U.S. Condom, 2021 - 2033 (USD Million)
  • Fig 52. U.S. condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 53. Canada estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 54. Canada Condom, 2021 - 2033 (USD Million)
  • Fig 55. Canada condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 56. Mexico estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 57. Mexico condom market, 2021 - 2033 (USD Million)
  • Fig 58. Mexico condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 59. Europe condom market, 2017 - 2033 (USD Million)
  • Fig 60. Europe condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 61. Germany estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 62. Germany condom market, 2021 - 2033 (USD Million)
  • Fig 63. Germany condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 64. UK estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 65. UK condom market, 2021 - 2033 (USD Million)
  • Fig 66. UK. condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 67. France estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 68. France condom market, 2021 - 2033 (USD Million)
  • Fig 69. France condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 70. Italy estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 71. Italy condom market, 2021 - 2033 (USD Million)
  • Fig 72. Italy. condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 73. Spain estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 74. Spain condom market, 2021 - 2033 (USD Million)
  • Fig 75. Spain. condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 76. Denmark estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 77. Denmark condom market, 2021 - 2033 (USD Million)
  • Fig 78. Denmark condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 79. Sweden estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 80. Sweden condom market, 2021 - 2033 (USD Million)
  • Fig 81. Sweden condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 82. Norway estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 83. Norway condom market, 2021 - 2033 (USD Million)
  • Fig 84. Norway condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 85. Netherlands estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 86. Netherlands condom market, 2021 - 2033 (USD Million)
  • Fig 87. Netherlands condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 88. Switzerland estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 89. Switzerland condom market, 2021 - 2033 (USD Million)
  • Fig 90. Switzerland condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 91. Portugal estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 92. Portugal condom market, 2021 - 2033 (USD Million)
  • Fig 93. Portugal condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 94. Asia Pacific condom market, 2021 - 2033 (USD Million)
  • Fig 95. Asia Pacific condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 96. China estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 97. China condom market, 2021 - 2033 (USD Million)
  • Fig 98. China condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 99. Japan estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 100. Japan condom market, 2021 - 2033 (USD Million)
  • Fig 101. Japan. condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 102. India estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 103. India condom market, 2021 - 2033 (USD Million)
  • Fig 104. India condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 105. South Korea estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 106. South Korea condom market, 2021 - 2033 (USD Million)
  • Fig 107. South Korea condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 108. Australia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 109. Australia condom market, 2021 - 2033 (USD Million)
  • Fig 110. Australia condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 111. Thailand estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 112. Thailand condom market, 2021 - 2033 (USD Million)
  • Fig 113. Thailand condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 114. Latin America condom market, 2021 - 2033 (USD Million)
  • Fig 115. Latin America condom market volume estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 116. Brazil estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 117. Brazil condom market, 2021 - 2033 (USD Million)
  • Fig 118. Brazil condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 119. Argentina estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 120. Argentina condom market, 2021 - 2033 (USD Million)
  • Fig 121. Argentina condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 122. MEA condom market, 2017 - 2033 (USD Million)
  • Fig 123. MEA condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 124. South Africa estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 125. South Africa condom market, 2021 - 2033 (USD Million)
  • Fig 126. South Africa condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 127. Nigeria estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 128. Nigeria condom market, 2021 - 2033 (USD Million)
  • Fig 129. Nigeria condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 130. Saudi Arabia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 131. Saudi Arabia condom market, 2021 - 2033 (USD Million)
  • Fig 132. Saudi Arabia condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 133. UAE estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 134. UAE condom market, 2021 - 2033 (USD Million)
  • Fig 135. UAE condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 136. Kuwait estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 137. Kuwait condom market, 2021 - 2033 (USD Million)
  • Fig 138. Kuwait condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 139. Kenya estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 140. Kenya condom market, 2021 - 2033 (USD Million)
  • Fig 141. Kenya condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 142. Zambia estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 143. Zambia condom market, 2021 - 2033 (USD Million)
  • Fig 144. Zambia condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 145. Zimbabwe estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 146. Zimbabwe condom market, 2021 - 2033 (USD Million)
  • Fig 147. Zimbabwe condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 148. Uganda estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)
  • Fig 149. Uganda condom market, 2021 - 2033 (USD Million)
  • Fig 150. Uganda condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 151. Egypt estimated prevalence of HIV/AIDs and STIs, 2021 - 2033 ('000)Egypt condom market, 2021 - 2033 (USD Million)
  • Fig 152. Egypt condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 153. Turkey estimated prevalence of HIV/AIDS and STIs, 2021 - 2033 ('000)
  • Fig 154. Turkey condom market, 2021 - 2033 (USD Million)
  • Fig 155. Turkey condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 156. Ghana estimated prevalence of HIV/AIDS and STIs, 2021 - 2033 ('000)
  • Fig 157. Ghana condom market, 2021 - 2033 (USD Million)
  • Fig 158. Ghana condom market volume estimates and forecasts, 2021 - 2033 ('000)
  • Fig 159. Company categorization
  • Fig 160. Company market position analysis
  • Fig 161. Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!